Loretta M. Wedge - 18 May 2022 Form 4/A - Amendment Insider Report for Biofrontera Inc. (BFRI)

Reporting relationship: Director
Issuer ticker: BFRI
Reported as of: 18 May 2022
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 06 Jun 2022, 19:38:14 UTC
Original report date: 26 May 2022
Prior SEC filing: 02 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/Daniel Hakansson, Attorney-in-fact for Loretta M. Wedge

Key filing fact

Loretta M. Wedge filed Form 4/A - Amendment for Biofrontera Inc. (BFRI) on 06 Jun 2022.

Key facts

This page summarizes Loretta M. Wedge's Form 4/A - Amendment filing for Biofrontera Inc. (BFRI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2022, 19:38.

Change

Previous filing in this sequence was filed on 02 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BFRI transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +22,000
Change %
Price: $0.000000
Shares after: 22,000
Date: 18 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,000
Exercise price: $2.61
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests in twelve equal monthly installments beginning June 18, 2022.

SEC remarks

The Form 4, as originally filed on 5/26/2022, inadvertently reported an incorrect vesting schedule of three equal annual installments beginning May 18, 2023.